Results 191 to 200 of about 704,631 (338)

Köbner Phenomenon in a Rituximab-Treated Pemphigus Patient: Beware Disease Activity

Dermatology Practical & Conceptual, 2019
Soheil Tavakolpour, Hamidreza Mahmoudi, Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh   +4 more
doaj   +1 more source

Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets. [PDF]

MedComm (2020)
Song X, Liang H, Nan F, Chen W, Li J, He L, Cun Y, Li Z, Zhang W, Zhang D.   +9 more
europepmc   +1 more source

Autoimmune Rheumatic Diseases [PDF]

, 1988
Peter H. Venables
openalex   +1 more source

Genetic Engineering Methods in Primary T Cells

Advanced Therapeutics, EarlyView.
Primary T cells can be engineered to confer them with novel therapeutic functions, allowing them to treat a variety of conditions. Genetic engineering can be either stable or transient, aiming to either express or inhibit a target gene. This review discusses the various genetic engineering tools available as well as their characteristics and ...
Anthony Youssef, Hui‐Shan Li
wiley   +1 more source

Diagnosis of rheumatic and autoimmune diseases dataset. [PDF]

Data Brief
Mahdi MF, Jahani A, Abd DH.
europepmc   +1 more source

STRUCTURAL PROTEINS OF C-TYPE RNA LEUKEMIA VIRUSES AND AUTOIMMUNE DISEASES OF NEW ZEALAND MICE

, 1978
Takashi Yoshiki, Takashi Hayasaka, Tetsuo Itoh, Toshikazu Shirai, Hisami Ikeda, Makoto Katagiri   +5 more
openalex   +2 more sources

Loss of NR2F6 Protects from Salmonella Typhimurium Infection

Advanced Science, EarlyView.
Loss of nuclear receptor NR2F6 reduces tissue‐resident macrophage populations. Nr2f6‐deficient mice are protected from weight loss and bacterial load during infection with Salmonella Typhimurium. Pro‐inflammatory cytokines and iron levels are altered in infected Nr2f6‐deficient mice.
Johannes Woelk, Christa Pfeifhofer‐Obermair, Julia Benz, Natascha Brigo, Milena Bamberger, Alexeja Kleiter, Martin Hermann, Guenter Weiss, Natascha Hermann‐Kleiter   +8 more
wiley   +1 more source

Lactate and lactylation: emerging roles in autoimmune diseases and metabolic reprogramming. [PDF]

Front Immunol
Liu W, Yang R, Zhan Y, Yang X, Zeng H, Chen B, Zeng J, Hu T, Hu J, Xiao Q, Shao Y, Chen X.   +11 more
europepmc   +1 more source

Multivariate Screening and Automated Clustering of Macrophage Immunoreactome to Nanoparticles and Photothermal Therapy

Advanced Science, EarlyView.
Predicting immune responses to treatments, including nanomedicines, with high throughput test is challenging due to the immunoreactome's complexity and plasticity. A predictive screening platform integrating pathway activation and gene profiling in macrophages has been developed as a versatile tool for designing effective immunotherapies.
Sonia Becharef, Léa Jabbour, Nassima Bekaddour, Giulio Avveduto, Nathalie Luciani, Gautier Laurent, Rana Bazzi, Edouard Alphandery, Stéphane Roux, Amanda K. A. Silva, Kelly Aubertin, Jean‐Philippe Herbeuval, Florence Gazeau   +12 more
wiley   +1 more source

Editorial: Next generation therapeutic modality to cure autoimmune diseases. [PDF]

Front Immunol
Chen G, Wang C, Wan Q, Dong F, Radstake T.   +4 more
europepmc   +1 more source